Anupam Rasayan India Limited Q1 FY2027 Results
📊
Overview
📋
Detailed Analysis
Sentiment
Mixed
Executive Summary
Company Q1 FY2027: Revenue ₹654.98 Cr (vs ₹485.83 Cr YoY), PAT ₹51.22 Cr (vs ₹48.46 Cr YoY)
Q1 FY2027 consolidated revenue rose to ₹654.98 Cr driven by higher volumes in subsidiaries and other income, up from ₹485.83 Cr in Q1 FY2026. Consolidated profit after tax increased to ₹51.22 Cr versus ₹48.46 Cr YoY, with profit before tax at ₹69.68 Cr. Inventory movements (change in inventories -₹69.20 Cr) and elevated finance costs (₹49.19 Cr) shaped gross and financing margins in the quarter. The Board approved the appointment of a new COO on August 14, 2026, while consolidation includes a mix of high-performing and loss-making step-down subsidiaries that will influence near-term cashflow...Revenue from Operations (Q1 FY2027)Page 10
₹654.98 Crvs ₹485.83 Cr in Q1 FY2026
Total Revenue (Q1 FY2027)Page 10
₹667.52 Crvs ₹490.74 Cr in Q1 FY2026
Profit before exceptional items & tax (Q1 FY2027)Page 10
₹69.68 Crvs ₹62.85 Cr in Q1 FY2026
Profit after tax (Q1 FY2027)Page 10
₹51.22 Crvs ₹48.46 Cr in Q1 FY2026
Total Expenses (Q1 FY2027)Page 10
₹597.86 Crvs ₹427.89 Cr in Q1 FY2026
Finance Costs (Q1 FY2027)Page 10
₹49.19 Crvs ₹35.67 Cr in Q1 FY2026
Basic EPS - Owners (Q1 FY2027)Page 11
3.39vs 3.10 in Q1 FY2026
Key Highlights
8
Consolidated revenue increased to ₹654.98 Cr in Q1 FY2027 driven by higher sales from subsidiaries and other income.
Profit before tax improved to ₹69.68 Cr in Q1 FY2027, supporting higher attributable net profit to owners at ₹44.63 Cr.
Total expenses rose to ₹597.86 Cr in Q1 FY2027, reflecting higher material, employee and other operating spends versus prior year.
Finance costs were elevated at ₹49.19 Cr in Q1 FY2027 which will pressure net interest outflows if sustained.
Inventory movement was a meaningful margin driver with 'Changes in Inventories' at -₹69.20 Cr in Q1 FY2027, positively reducing cost of sales recognition in the quarter.
Other income contributed ₹12.57 Cr in Q1 FY2027 supporting consolidated top-line expansion.
+2 more in Detailed Analysis →
Key Highlights
8
Consolidated revenue increased to ₹654.98 Cr in Q1 FY2027 driven by higher sales from subsidiaries and other income.
Profit before tax improved to ₹69.68 Cr in Q1 FY2027, supporting higher attributable net profit to owners at ₹44.63 Cr.
Total expenses rose to ₹597.86 Cr in Q1 FY2027, reflecting higher material, employee and other operating spends versus prior year.
Finance costs were elevated at ₹49.19 Cr in Q1 FY2027 which will pressure net interest outflows if sustained.
A step-down subsidiary reported a very large loss (net loss after tax of ₹(6820.47) million) that is disclosed and impacts consolidated volatility.
Inventory movement was a meaningful margin driver with 'Changes in Inventories' at -₹69.20 Cr in Q1 FY2027, positively reducing cost of sales recognition in the quarter.
Other income contributed ₹12.57 Cr in Q1 FY2027 supporting consolidated top-line expansion.
Consolidation scope includes a material subsidiary with revenue of ₹151.97 Cr in Q1 FY2027, adding scale but also volatility from step-down entities.
Guidance & Outlook
4
Subsidiary Tanfac Industries Ltd. contributed revenue of ₹189.20 Cr in Q1 FY2027 and remains a material contributor to group top-line.
Board approved appointment of Mr. Ravi Desai as Chief Operating Officer effective August 14, 2026, indicating operational leadership strengthening.
Management continues to consolidate results from overseas subsidiaries including recently liquidated Monitchem Kansas S.a.r.l which remains part of disclosures.
Management disclosure indicates no segment reporting as the business is treated as a single specialty chemicals segment, implying capital allocation will be centrally managed.
Risks & Concerns
5
A step-down subsidiary posted an aggregate net loss of ₹(6,820.47) million which presents a major consolidation risk and potential impairment exposure.
High finance costs of ₹49.19 Cr in Q1 FY2027 increase interest burden and can compress net margins if funding costs persist.
Total expenses rose to ₹597.86 Cr in Q1 FY2027, outpacing revenue growth in parts of the cost base and risking margin pressure if not controlled.
Deferred tax swings (deferred tax ₹75.26 million credit in Q1 FY2027) indicate tax volatility that can impact quarterly PAT recognition.
Consolidation includes multiple overseas subsidiaries and associates which adds translation, regulatory and audit reliance risk from third‑party auditors.
AI-generated analysis. May contain inaccuracies — verify against original sources.